日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Autologous NK cells as consolidation therapy following stem cell transplantation in multiple myeloma

自体NK细胞作为多发性骨髓瘤干细胞移植后的巩固治疗

Hareth Nahi ,Michael Chrobok ,Stephan Meinke ,Charlotte Gran ,Nicole Marquardt ,Gabriel Afram ,Tolga Sutlu ,Mari Gilljam ,Birgitta Stellan ,Arnika K Wagner ,Pontus Blomberg ,Per-Henrik Holmqvist ,Lilian Walther-Jallow ,Karin Mellström ,Johan Liwing ,Charlotte Gustafsson ,Robert Månsson ,Monika Klimkowska ,Gösta Gahrton ,Johan Lund ,Per Ljungman ,Hans-Gustaf Ljunggren ,Evren Alici

Boosting Natural Killer Cell-Mediated Targeting of Sarcoma Through DNAM-1 and NKG2D

通过 DNAM-1 和 NKG2D 增强自然杀伤细胞介导的肉瘤靶向性

Ece Canan Sayitoglu, Anna-Maria Georgoudaki, Michael Chrobok, Didem Ozkazanc, Benjamin J Josey, Muhammad Arif, Kim Kusser, Michelle Hartman, Tamara M Chinn, Renee Potens, Cevriye Pamukcu, Robin Krueger, Cheng Zhang, Adil Mardinoglu, Evren Alici, Harry Thomas Temple, Tolga Sutlu, Adil Doganay Duru1

Engineering antigen-specific NK cell lines against the melanoma-associated antigen tyrosinase via TCR gene transfer

通过 TCR 基因转移设计针对黑色素瘤相关抗原酪氨酸酶的抗原特异性 NK 细胞系

Ayhan Parlar, Ece Canan Sayitoglu, Didem Ozkazanc, Anna-Maria Georgoudaki, Cevriye Pamukcu, Mertkaya Aras, Benjamin J Josey, Michael Chrobok, Suzanne Branecki, Pegah Zahedimaram, Lolai Ikromzoda, Evren Alici, Batu Erman, Adil D Duru, Tolga Sutlu

Infectious complications and NK cell depletion following daratumumab treatment of Multiple Myeloma

达雷木单抗治疗多发性骨髓瘤后的感染并发症和 NK 细胞耗竭

Hareth Nahi, Michael Chrobok, Charlotte Gran, Johan Lund, Astrid Gruber, Gösta Gahrton, Per Ljungman, Arnika Kathleen Wagner, Evren Alici